Article Versions Notes

Shipley R, Wright E, Smith SP, Selden D, Fooks AR, Banyard AC. Taiwan Bat Lyssavirus: In Vitro and In Vivo Assessment of the Ability of Rabies Vaccine-Derived Antibodies to Neutralise a Novel Lyssavirus. Viruses. 2022; 14(12):2750. https://doi.org/10.3390/v14122750

Shipley, Rebecca, Edward Wright, Samuel P. Smith, David Selden, Anthony R. Fooks, and Ashley C. Banyard. 2022. "Taiwan Bat Lyssavirus: In Vitro and In Vivo Assessment of the Ability of Rabies Vaccine-Derived Antibodies to Neutralise a Novel Lyssavirus" Viruses 14, no. 12: 2750. https://doi.org/10.3390/v14122750

Shipley, R., Wright, E., Smith, S. P., Selden, D., Fooks, A. R., & Banyard, A. C. (2022). Taiwan Bat Lyssavirus: In Vitro and In Vivo Assessment of the Ability of Rabies Vaccine-Derived Antibodies to Neutralise a Novel Lyssavirus. Viruses, 14(12), 2750. https://doi.org/10.3390/v14122750